Advertisement

FDA OKs 1st Generic Nasal Spray of Overdose Reversal Drug

U.S. regulators have approved the first generic nasal spray version of Narcan, a drug that reverses opioid overdoses. U.S. regulators have approved the first generic nasal spray version of Narcan, a drug that reverses opioid overdoses. |  Photo: WDIO/MGN

LINDA A. JOHNSON AP Medical Writer
Created: April 19, 2019 02:23 PM

U.S. regulators have approved the first generic nasal spray version of Narcan, a drug that reverses opioid overdoses.
    
The Food and Drug Administration on Friday OK'd naloxone spray from Israel's Teva Pharmaceuticals.
    
Naloxone has been sold as a nasal spray in the U.S. since 2016 under the brand name Narcan. Pharmacists can dispense it without a prescription. It is also sold as a generic or brand-name drug in automatic injectors, prefilled syringes and vials.
    
A pack of two Narcan nasal sprays cost about $130 to $150 without insurance. Teva didn't immediately provide the product's price or when it will be available; its offices were closed Friday.
    
More than 47,600 Americans died of opioid overdoses in 2017, a toll that has been rising for two decades.
 

Advertisement – Content Continues Below

Credits

LINDA A. JOHNSON AP Medical Writer

Copyright 2019 The Associated Press. All rights reserved.

Advertisement
Advertisement
Relay Media Amp

Protesters Disrupt 1st Meeting on Minnesota Police Shootings

After Nearly 70 Years, Ashland Family Says 'Goodbye' to Fallen Veteran

Central St. Louis Co. Fair Bringing Fun to Meadowlands

Bear Blamed in Highway 2 Crash

ArcelorMittal Apologizes for Spill that Killed Fish, Closed Beaches

Bad River Band Granted Funds for Green Projects

Advertisement